How CBD Could Transform Women’s Health & Wellness
October 4th, 2022
App, News, Top Story
Cannabidiol, or CBD, has become one of the world’s most popular health and wellness supplements. According to the Brightfield Group, CBD sales could reach $16 billion in the U.S. alone. A growing body of evidence suggests that CBD could be beneficial in treating many health concerns, while upcoming FDA regulations could boost public confidence.
Sexual health and wellness represent a growing market where CBD products could prove beneficial. According to Arizton, the U.S. sexual wellness market could reach $9.34 billion by 2026, growing at an 8.27% compound annual growth rate. And many researchers believe that CBD could play a central role over the coming years.
How CBD Impacts Women’s Health
The human endocannabinoid system helps regulate everything from learning and memory to inflammatory and immune responses. So, not surprisingly, emerging research suggests that cannabinoids like CBD may influence sexual health and wellness through many mechanisms of action – including stress relief, inflammation reduction, and more.
While CBD is not psychoactive like its cousin THC, it boosts a neurotransmitter known as anandamide. Anandamide influences oxytocin, or the “cuddle hormone,” and helps increase endorphins and other neurotransmitters that improve mood. And ultimately, that can help women remain calm and focused on enjoyment.
The numerous cannabinoid receptors in reproductive organs and sexual tissues also mean that CBD may help increase blood flow to tissues. As a result, women could see greater sensitivity and promote the body’s natural lubrication. And these dynamics could help promote fewer painful experiences and more pleasurable experiences.
CBD could also have an impact on several related medical conditions, including:
- Pelvic Floor Dysfunction
- Vaginal Scarring
- Candida & Fungal Infections
- Ovarian Cysts
- Vaginal Dryness
These markets could be worth billions of dollars per year and affect millions of women in the United States and around the world.
How to Invest in the Growing Niche
BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN), a newly public cannabis and software business based in Israel, recently signed a share purchase agreement to acquire the developers of EZ-G, a therapeutic device that uses low concentrations of CBD oils to treat certain women’s reproductive health issues and improve sexual health and wellness.
In particular, the unique, patent-pending device uses proprietary software to regulate the flow of low-concentration CBD oils into the soft tissues of the female reproductive system. According to research conducted across the globe, treatment with low-concentration CBD oils can relieve candida, dryness, scars, and many other female health issues.
The company intends to pursue the final registration of the patent and establish a marketing and sales system for the EZ-G device focused on both B2B and B2C channels. In the meantime, the company plans to start prototype production, validation tests, and contracts with suppliers to produce the device and the oils used.
CBD has the potential to transform women’s sexual health and wellness through both physiological and psychological mechanisms of action. While there is no shortage of CBD oils and other products, BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) is developing an innovative medical device and aims to secure FDA approval.
In addition to the EZ-G, BYND owns and operates a customer relationship management (CRM) solution – including a cannabis-specific CRM solution for medical marijuana growers. They’re also in the process of acquiring a cannabis license, enabling them to sell cannabis products in Israel, as well as export products to Germany and other European markets.
For more information, visit the company’s website.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.